Emergent BioSolutions
Stock Forecast, Prediction & Price Target

	Passed			Analyst forecast
Metric	12/31/2021	12/31/2022	12/31/2023	12/31/2025	12/31/2026	12/31/2027
Revenue % change YoY	$1.79B N/A	$1.12B -37.47%	$1.04B -6.38%	Avg: $1.13B Low: $1.13B High: $1.14B avg. 8.43%	Avg: $1.14B Low: $1.13B High: $1.15B avg. 0.48%	Avg: $904.5M Low: $898.84M High: $910.15M avg. -20.89%
Net Income % change YoY	$219.5M N/A	$-223.8M -201.95%	$-760.5M -239.81%	Avg: $-110.33M Low: $-108.68M High: $-106.93M avg. 85.49%	Avg: $-112.29M Low: $-109.56M High: $-107.80M avg. -1.77%	Avg: $-51.71M Low: $-52.13M High: $-51.29M avg. 53.94%
EBITDA % change YoY	$514.4M N/A	$-34.4M -106.68%	$-505.29M -1368.89%	Avg: $176.51M Low: $175.41M High: $177.61M avg. 134.93%	Avg: $177.37M Low: $176.26M High: $178.48M avg. 0.48%	Avg: $140.32M Low: $139.44M High: $141.20M avg. -20.89%
EPS % change YoY	$4.1 N/A	-$4.47 -209.02%	-$14.85 -232.21%	Avg: -$2.11 Low: -$2.12 High: -$2.09 avg. 85.82%	Avg: -$2.12 Low: -$2.14 High: -$2.11 avg. -0.80%	Avg: -$1.01 Low: -$1.02 High: -$1 avg. 52.41%
Operating Expenses % change YoY	$640.9M N/A	$593.2M -7.44%	$1.04B 75.99%	Avg: $291.31M Low: $289.49M High: $293.13M avg. -72.09%	Avg: $292.73M Low: $290.90M High: $294.56M avg. 0.48%	Avg: $231.58M Low: $230.13M High: $233.02M avg. -20.89%

FAQ

Wall Street analysts estimate the annual average earnings growth rate of 45.88% in 2025-2027.

We have gathered data from 1 analysts. Their low estimate is -108.68M, average is -110.33M and high is -106.93M.

Wall Street analysts forecast annual average revenue growth of -3.98% in 2025-2027.

We have gathered data from 1 analysts. Their low revenue estimate is $1.13B, average is $1.13B and high is $1.14B.

Wall Street analysts forecast annual average earnings growth of 45.81% in 2025-2027.

We have gathered data from 1 analysts. Their low earnings per share estimate is -$2.12, average is -$2.11 and high is $-2.08.